WebDose-dense doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) chemotherapy for adjuvant treatment of breast cancer [1] This table is provided as an example of how to administer this regimen; there may be other acceptable methods. WebNov 28, 2024 · Cyclophosphamide can harm an unborn baby if the mother or the father is using cyclophosphamide. If you are a woman, do not use cyclophosphamide if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 1 year after your last dose.

Cyclophosphamide Tablets: Indications, Side Effects, Warnings

WebApr 11, 2024 · (Rush et al., 2024, Muraro et al., 2024) But an unwanted side effect in young women of fertile age to the conditioning regimen used before transplantation is infertility. Conditioning regimens consist of combination chemotherapy with alkylating agents such as cyclophosphamide and busulfan, both of which have a known gonadotoxic effect. WebTotal cyclophosphamide 5 g/m2 in women age 30- 40 Multiple cancers, breast AC for breast cancer x4 + paclitaxel or Docetaxel in women age < 40 Breast Monoclonal … frp zte a71

Reproductive outcome after transplantation of ovarian tissue

WebIntroduction. Breast cancer is one of the most frequently diagnosed malignancies in women worldwide, and the probability of developing breast cancer before the age 40 years is approximately 1 for every 200 women. 1 In the reproductive-age women with malignant disease, breast cancer patient’s accounts for more than 40%. 2 Breast cancer in young … WebAs with females, the severity and risk of gonadal toxicity from cyclophosphamide exposure is dependent on gonadal activity at the time of treatment (prepubertal vs. … WebCyclophosphamide can affect your fertility. This is your ability to become pregnant or father a child. If this is an issue for you, speak to your doctor before you start treatment. … frp zte l7 nck